Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

Conditions: Pancreatic Adenocarcinoma; Homologous Recombination Deficiency Interventions: Drug: Cisplatin Sponsors: Fudan University Not yet recruiting

https://clinicaltrials.gov/study/NCT06095141

Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials